Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2016, Article ID 5134969, 3 pages
http://dx.doi.org/10.1155/2016/5134969
Case Report

Community-Acquired Moraxella catarrhalis Bacteremic Pneumonia: Two Case Reports and Review of the Literature

Hospital Universitario Central de Asturias (HUCA), Instituto Nacional de Silicosis (INS), Área del Pulmón, Facultad de Medicina, Universidad de Oviedo, 33005 Oviedo, Spain

Received 4 January 2016; Accepted 2 February 2016

Academic Editor: Fabio Midulla

Copyright © 2016 Miguel Angel Ariza-Prota et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. W. Catlin, “Branhamella catarrhalis: an organism gaining respect as a pathogen,” Clinical Microbiology Reviews, vol. 3, no. 4, pp. 293–320, 1990. View at Google Scholar · View at Scopus
  2. M. C. Enright and H. McKenzie, “Moraxella (Branhamella) catarrhalis—clinical and molecular aspects of a rediscovered pathogen,” Journal of Medical Microbiology, vol. 46, no. 5, pp. 360–371, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. C. M. Verduin, C. Hol, A. Fleer, H. van Dijk, and A. van Belkum, “Moraxella catarrhalis: from emerging to established pathogen,” Clinical Microbiology Reviews, vol. 15, no. 1, pp. 125–144, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. J. P. A. Ioannidis, M. Worthington, J. K. Griffiths, and D. R. Snydman, “Spectrum and significance of bacteremia due to Moraxella catarrhalis,” Clinical Infectious Diseases, vol. 21, no. 2, pp. 390–397, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Pórsson, V. Haraldsdóttir, and M. Kristjánsson, “Moraxella catarrhalis bacteraemia. A report on 3 cases and a review of the literature,” Scandinavian Journal of Infectious Diseases, vol. 30, no. 2, pp. 105–109, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. D. R. Graham, J. D. Band, C. Thornsberry, D. G. Hollis, and R. E. Weaver, “Infections caused by Moraxella, Moraxella urethralis, Moraxella-like groups M-5 and M-6, and Kingella kingae in the United States, 1953–1980,” Reviews of Infectious Diseases, vol. 12, no. 3, pp. 423–431, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. P. W. Wright, R. J. Wallace Jr., and J. R. Shepherd, “A descriptive study of 42 cases of Branhamella catarrhalis pneumonia,” American Journal of Medicine, vol. 88, supplement 1, no. 5, pp. S2–S8, 1990. View at Google Scholar · View at Scopus
  8. F. A. Sarubbi, J. W. Myers, J. J. Williams, and C. G. Shall, “Respiratory infections caused by Branhamella catarrhalis. Selected epidemiologic features,” The American Journal of Medicine, vol. 88, supplement 5, pp. 9S–14S, 1990. View at Google Scholar
  9. J. A. García-Rodríguez, F. J. Baquero, J. García de Lomas, and L. Aguilar, “Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates from respiratory tract infections in Spain: results of 1-year (1996-97) multicenter surveillance study,” Infection, vol. 27, pp. 265–267, 1999. View at Google Scholar
  10. E. Pérez-Trallero, C. García de la Fuente, C. García-Rey et al., “Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 5, pp. 1965–1972, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Wallace, V. A. Steingrube, D. R. Nash et al., “BRO β-lactamases of Branhamella catarrhalis and subgenus Moraxella, including evidence for chromosomal β-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata,” Antimicrobial Agents and Chemotherapy, vol. 33, no. 11, pp. 1845–1854, 1989. View at Google Scholar
  12. L. Robledano, M. J. Rivera, I. Otal, and R. Gómez-Lus, “Enzymatic modification of aminoglycoside antibiotics by Branhamella catarrhalis carrying an R factor,” Drugs under Experimental and Clinical Research, vol. 13, no. 3, pp. 137–143, 1987. View at Google Scholar
  13. K. Hasegawa, K. Yamamoto, N. Chiba et al., “Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States,” Microbial Drug Resistance, vol. 9, no. 1, pp. 39–46, 2003. View at Google Scholar · View at Scopus
  14. K. Hasegawa, N. Chiba, R. Kobayashi et al., “Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 5, pp. 1509–1514, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Ubukata, “BLNAR (beta-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae),” Nippon Rinsho, vol. 61, supplement 3, pp. 176–181, 2003. View at Google Scholar · View at Scopus